z-logo
Premium
Can reducing cosmetic substances help prevent chromate contact allergy?
Author(s) -
Lejding Tina,
Engfeldt Malin,
Bruze Magnus,
Isaksson Marléne,
Svedman Lena Persson, Cecilia,
Zimerson Erik,
Mowitz Martin
Publication year - 2020
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/cod.13426
Subject(s) - chemistry , reducing agent , dihydroxyacetone , allergic contact dermatitis , sulfate , contact dermatitis , acetylcysteine , chromate conversion coating , nuclear chemistry , allergy , dermatology , medicine , antioxidant , organic chemistry , chromium , glycerol , immunology
Background Allergic contact dermatitis caused by Cr(VI) is often severe and difficult to treat. Therefore, primary prevention is a main goal but, secondary prevention can be valuable to ease the symptoms or prevent relapse of Cr(VI) dermatitis when sensitization has occurred. Barrier creams have been tried for many chemical substances, but until now there is no successful barrier cream against Cr(VI). Objectives To investigate the ability of reducing agents to transform Cr(VI) into Cr(III) in an experimental situation, in order to find suitable chemicals to investigate for possible use in a barrier cream. Methods The capacity to reduce the amount of Cr(VI) was analyzed in water solutions of acetylcysteine, cysteine, dihydroxyacetone, glutathione, and iron sulfate heptahydrate. Thereafter the reducing capacity of acetylcysteine, dihydroxyacetone, glutathione, and iron sulfate on the amount of Cr(VI) in cement extracts was investigated. The content of Cr(VI) in the test solutions and in the cement extracts was estimated by the diphenyl carbazide spot test. Results All of the chosen chemicals reduced the amount of Cr(VI) in the test solutions and in the cement extracts to some extent. The reducing capacity was most prominent for iron sulfate. Conclusion A reducing capacity was found for all chosen chemicals.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here